Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nuclear division machinery in Eimeria species is a complex assembly of structural and regulatory proteins that orchestrates the parasite's rapid asexual (schizogony) and sexual (gametogony) replication within host intestinal cells (Mehlhorn et al., 1984). This machinery is central to the process of schizogony, where multiple rounds of nuclear division occur within a single cytoplasm before cytokinesis, requiring a specialized mitotic spindle composed of alpha- and beta-tubulins and regulated by spindle pole bodies (Reid et al., 2014). Key regulatory components include cyclin-dependent kinases, such as Eimeria tenella CDK-related kinase 2 (EtCRK2), which have been chemically validated as drug targets for their essential role in cell cycle progression (Engels et al., 2010). This machinery is a critical therapeutic target because its disruption halts the parasite's life cycle, preventing the massive cellular destruction and clinical symptoms associated with coccidiosis in poultry and livestock. Anticoccidial drugs like toltrazuril and dinitroanilines (e.g., oryzalin) are known to interfere with these processes by disrupting microtubule dynamics or causing swelling and disintegration of the dividing nuclei (Mehlhorn et al., 1984; Engels et al., 2010).
Inhibition of microtubule polymerization, inhibition of cyclin-dependent kinases (e.g., EtCRK2), and disruption of nuclear structural integrity during schizogony.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear division machinery (Eimeria spp.).